Critical Data From Echo and Galectin Therapeutics Soon

Today, I have three items on a few of the companies that are going to power this revolution. None of them is new to you, but all are worth updating. One is very important news regarding BioTime Inc. Andrew von Eschenbach, head of the FDA under

Related Posts:

• July 17, 2012 -- BioTime Licenses Matrix for Eye Drug Delivery and Echo Therapeutics Expands License Agreement to Deliver Anesthetic
• August 2, 2012 -- Breaking News From Echo Therapeutics and BioTime
• July 20, 2012 -- The Phoenix Event: One Company that Holds the Keys to Life Everlasting
• August 31, 2011 -- Six Breakthrough Companies for Generations of Lasting Wealth
• August 19, 2011 -- International Stem Cell Corp.: Mass Marketing Regenerative Medicine